『Hematology / Oncology @Point of Care Podcasts』のカバーアート

Hematology / Oncology @Point of Care Podcasts

Hematology / Oncology @Point of Care Podcasts

著者: @Point of Care
無料で聴く

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり
Our @Point of Care Hematology & Oncology Podcasts have healthcare experts discussing and providing information related to oncology diagnosis, treatment, management, and other important information.Copyright 2020 At Point of Care, LLC. All rights reserved. 衛生・健康的な生活 身体的病い・疾患
エピソード
  • S34:E2 – Integrating Oral SERDs into the Management of HR+/HER2- Advanced Breast Cancer
    2026/09/22

    Explore the evolving role of oral SERDs in HR-positive, HER2-negative advanced breast cancer. Hear expert perspectives on ESR1 mutation testing, treatment selection and sequencing, emerging combination strategies, circulating tumor DNA (ctDNA) monitoring, and safety considerations that may inform individualized treatment decisions.

    Visit https://suitehome.atpointofcare.com/library/2760.12/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

    This podcast is powered by Pinecast.

    続きを読む 一部表示
    30 分
  • S34:E1 – ESR1 Mutations in Advanced Breast Cancer: The Evolving Role of Oral SERDs
    2026/09/22

    Stay ahead of evolving endocrine resistance in HR-positive, HER2-negative advanced breast cancer. Discover how ESR1 mutations are reshaping treatment decisions, and explore expert perspectives on mutation testing, oral SERDs, and emerging serial monitoring strategies that may help identify resistance earlier and inform individualized patient care.

    Visit https://suitehome.atpointofcare.com/library/2760.11/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

    This podcast is powered by Pinecast.

    続きを読む 一部表示
    29 分
  • S33:E2 – Navigating the KRAS Pipeline: Clinical Implications for Pancreatic Cancer Care
    2026/09/09

    RAS-targeted therapies are reshaping the treatment landscape for pancreatic ductal adenocarcinoma, creating new challenges in understanding the mechanisms and potential clinical applications of allele-specific, pan-KRAS, and pan-RAS inhibitors. Join Dr. Eileen O’Reilly and Dr. Margaret Tempero as they explore the evolving RAS therapeutic pipeline and discuss how these emerging strategies may inform future treatment decisions.

    Visit https://suitehome.atpointofcare.com/library/2746.02/page/0 to view the activity and CME/CE information, download the transcript, and complete the posttest and evaluation to earn CME/CE credit.

    This podcast is powered by Pinecast.

    続きを読む 一部表示
    29 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません